UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of a product‐specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4), p.e335-e339

2017

Volltextzugriff (PDF)

Accuracy and consistency of anti‐Xa activity measurement for determination of rivaroxaban plasma levels

Journal of thrombosis and haemostasis, 2017-08, Vol.15 (8), p.1576-1583

2017

Volltextzugriff (PDF)

Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation

Transplant infectious disease, 2009-04, Vol.11 (2), p.100-105

2009

Volltextzugriff (PDF)

Impact of electronic reminders on venous thromboprophylaxis after admissions and transfers

Journal of the American Medical Informatics Association : JAMIA, 2014-10, Vol.21 (e2), p.e297-e303

2014

Volltextzugriff (PDF)

Measurement of von Willebrand factor‐cleaving protease (ADAMTS‐13) activity in plasma: a multicenter comparison of different assay methods

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.1882-1887

2003

Volltextzugriff (PDF)

Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response

Hämostaseologie, 2013-05, Vol.33 (2), p.121-130

2013

Volltextzugriff (PDF)

Heparin-induced thrombocytopenia associated with thrombotic microangiopathy

Hämostaseologie, 2013, Vol.33 (2), p.160-163

2013

Volltextzugriff (PDF)

Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas

Journal of thrombosis and haemostasis, 2004-09, Vol.2 (9), p.1601-1609

2004

Volltextzugriff (PDF)

Thrombotic microangiopathies

Hämostaseologie, 2008-12, Vol.28 (5), p.358

Studt, J-D

2008

Volltextzugriff (PDF)

Thrombotische Mikroangiopathien

Hämostaseologie, 2008, Vol.28 (5), p.358-364

Studt, J.-D.

2008

Volltextzugriff (PDF)

Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory

Swiss medical weekly, 2003-06, Vol.133 (23-24), p.325

2003

Volltextzugriff (PDF)

Deficiency of ADAMTS‐13 in thrombotic and thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2003-09, Vol.1 (9), p.2042-2044

2003

Volltextzugriff (PDF)

Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2

Hämostaseologie, 2003-08, Vol.23 (3), p.103-108

2003

Volltextzugriff (PDF)

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry

American journal of clinical pathology, 2001-10, Vol.116 (4), p.567-574

2001

Volltextzugriff (PDF)

ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

Blood, 2003-07, Vol.102 (1), p.60-68

2003

Volltextzugriff (PDF)

Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory

Swiss medical weekly, 2003-06

2003

Volltextzugriff (PDF)

Impact of a product‐specific reference standard for the measurement of a PEG ylated rFVIII activity: the Swiss Multicentre Field Study

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-07, Vol.23 (4)

2017

Volltextzugriff (PDF)

Humanitas COVID-19 Task Force Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in Milan, Italy

Journal of vascular surgery. Venous and lymphatic disorders (New York, NY), 2020-11, Vol.8 (6), p.1119-1119

2020

Volltextzugriff (PDF)

Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor

Haematologica (Roma), 2011-01, Vol.96 (1), p.150-155

2011

Volltextzugriff (PDF)

Epitope mapping of ADAMTS 13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Blood, 2004-06, Vol.103 (12), p.4514-4519

2004

Volltextzugriff (PDF)

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

Blood, 2005-01, Vol.105 (2), p.542-544

2005

Volltextzugriff (PDF)

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor‐cleaving protease activity by recombinant human ADAMTS13

British journal of haematology, 2003-03, Vol.120 (5), p.821-824

2003

Volltextzugriff (PDF)

Assessing the Capital Efficiency of Healthcare Information Technologies Investments: An Econometric Perspective

Yearbook of medical informatics, 2008, Vol.17 (1), p.114-127

2008

Volltextzugriff (PDF)

Questions and answers regarding the use of rivaroxaban in daily practice

Revue médicale suisse, 2013, Vol.9 (392), p.1375

2013

Volltextzugriff (PDF)

Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience

Seminars in hematology, 2004, Vol.41 (1), p.75-82

2004

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(30)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(23)
Hematology
(20)
Adamts13 Protein
(15)
Adam Proteins
(13)
Female
(11)
Male
(11)
Adult
(10)
Middle Aged
(10)
Metalloendopeptidases - Deficiency
(9)
Thrombotic Thrombocytopenic Purpura
(9)
Biological And Medical Sciences
(8)
Hematologic And Hematopoietic Diseases
(8)
Medical Sciences
(8)
Metalloendopeptidases - Blood
(8)
Aged
(7)
Platelet Diseases And Coagulopathies
(7)
Purpura, Thrombotic Thrombocytopenic - Diagnosis
(7)
Adolescent
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of a product‐specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study

Accuracy and consistency of anti‐Xa activity measurement for determination of rivaroxaban plasma levels

Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation

Impact of electronic reminders on venous thromboprophylaxis after admissions and transfers

Measurement of von Willebrand factor‐cleaving protease (ADAMTS‐13) activity in plasma: a multicenter comparison of different assay methods

Acquired thrombotic thrombocytopenic purpura. Development of an autoimmune response

Heparin-induced thrombocytopenia associated with thrombotic microangiopathy

Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas

Thrombotic microangiopathies

Thrombotische Mikroangiopathien

Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory

Deficiency of ADAMTS‐13 in thrombotic and thrombocytopenic purpura

Schistocytic anaemia, severe thrombocytopenia, and renal dysfunction: thrombotic microangiopathy due to severe acquired ADAMTS-13 deficiency. Case 2

Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry

ADAMTS13 activity in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients

Von Willebrand factor-cleaving protease (ADAMTS-13) activity in thrombotic microangiopathies: diagnostic experience 2001/2002 of a single research laboratory

Impact of a product‐specific reference standard for the measurement of a PEG ylated rFVIII activity: the Swiss Multicentre Field Study

Humanitas COVID-19 Task Force Venous and Arterial Thromboembolic Complications in COVID-19 Patients Admitted to an Academic Hospital in Milan, Italy

Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor

Epitope mapping of ADAMTS 13 autoantibodies in acquired thrombotic thrombocytopenic purpura

Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor‐cleaving protease activity by recombinant human ADAMTS13

Assessing the Capital Efficiency of Healthcare Information Technologies Investments: An Econometric Perspective

Questions and answers regarding the use of rivaroxaban in daily practice

Von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience

Suchergebnisse filtern